Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Targeting NR2 NMDA receptor subunit useful in early experimental parkinsonism

Dec. 9, 2008

Pozen reports positive top-line phase III results for PN-400

Dec. 5, 2008

INI treats first patient in phase I/II clinical trial of CellMed's CellBeads for stroke

Dec. 5, 2008

Gene therapy can restore arylsulfatase A expression, possibly treat metachromatic leukodystrophy

Dec. 5, 2008

Neuroprotective effects and improved motor performance with metal-chelating agent in PD

Dec. 5, 2008

Inhibition of nigrostriatal-thalamic pathway by Trap-101 beneficial in model of PD

Dec. 5, 2008

MonoSol Rx and Strativa complete bioequivalence studies for ondansetron thin film NDA

Dec. 5, 2008

New positive modulator of GABA-B receptors identified at Novartis

Dec. 4, 2008

Mechanistically distinct drugs developed by PainCeptor, effective in pain models

Dec. 4, 2008

Two pivotal HZT-501 phase III trials meet primary endpoints

Dec. 4, 2008

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026